13F HOLDINGS REPORT
MPM ASSET MANAGEMENT LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000950123-23-010947
Total Value
$186.7M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Entrada Therapeutics, Inc. | TRDA | 4,425,784 | $69.9M | 37.45% |
| 2 | Dyne Therapeutics, Inc. | DYN | 4,951,303 | $44.4M | 23.76% |
| 3 | iTeos Therapeutics, Inc. | 46565G104 | 2,738,785 | $30.0M | 16.06% |
| 4 | Repare Therapeutics, Inc. | 760273102 | 2,242,636 | $27.1M | 14.51% |
| 5 | Werewolf Therapeutics, Inc. | HOWL | 4,284,172 | $9.2M | 4.91% |
| 6 | Adaptimmune Therapeutics plc | ADTI | 6,287,101 | $4.9M | 2.63% |
| 7 | Harpoon Therapeutics, Inc. | 41358P106 | 313,136 | $1.3M | 0.68% |